Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

• Príomhchruthaitheoirí: Lourens T. Bloem (Údar), Rick A. Vreman (Údar), Niels W. L. Peeters (Údar), Jarno Hoekman (Údar), Menno E. van derElst (Údar), Hubert G. M. Leufkens (Údar), Olaf H. Klungel (Údar), Wim G. Goettsch (Údar), Aukje K. Mantel‐Teeuwisse (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Wiley, 2021-07-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract We aimed to determine whether uncertainties identified by the European Medicines Agency (EMA) were associated with negative relative effectiveness assessments (REAs) and negative overall reimbursement recommendations by national health technology assessment (HTA) agencies. Therefore, we ide...